Off-Label Use of Neovasculgen for II-III Degree Foot Frostbite: A Case Report

• Main Authors: R. V. Ishchenko (Author), E. Ya. Fistal (Author), D. A. Filimonov (Author), M. V. Pokrovskii (Author), V. V. Arkhipov (Author), S. V. Nalyotov (Author), V. V. Arefiev (Author), V. V. Makienko (Author), E. N. Nalyotova (Author)
• Format: Book
• Published: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», 2022-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

INTRODUCTION. The high mortality and disability rates associated with cold injury are often a consequence of urgent amputation or disarticulation surgery. The use of the Russian gene therapy product Neovasculgen can decrease the amputation rate in patients with chronic limb ischaemia through prevent...